MedPath

The clinical effect of pregabalin on neuropathic pain in central sensitized patients who are treated with duloxetine after total knee arthroplasty: Randomized Controlled Trial

Not Applicable
Conditions
Diseases of the musculoskeletal system and connective tissue
Registration Number
KCT0007301
Lead Sponsor
The Catholic University of Korea, Seoul St. Mary's Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
90
Inclusion Criteria

? Patients for total knee arthroplasty over the age of 19.
? Patients who have the will or ability to follow the doctor's instructions, including rehabilitation treatment such as joint exercise.
? Patients understand this study and agree in writing by the patient's own or by the patient's representative to participate in the study.
? Patients with central sensitization and neuropathic pain.

Exclusion Criteria

? Local infection, sepsis, or neurological abnormalities in the lower extremities of the surgical site.
? Patients with inflammatory arthritis or crystalline sedimentary arthritis.
? Patients who are hypersensitive to duloxetin or prevalin sanctions or show excessive complications.
? Patients who received treatment for anemia within a month of surgery.
? Patients with uncontrolled hypertension with relaxed blood pressure of 100mmHg or more
? Patients with abnormal liver function (aspartate aminotransferase or alanine aminotransferase >60 IU litre)
? Patients who can't do rehabilitation alone or need assistance.

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Visual Pain Scale
Secondary Outcome Measures
NameTimeMethod
Western Ontario and McMaster University Arthritis Index (WOMAC) Scale;Knee range of motion
© Copyright 2025. All Rights Reserved by MedPath